Strategies for Optimizing Therapy
Panelists discuss how barriers to optimizing TD therapy include insurance coverage limitations, high medication costs, delayed diagnosis, lack of provider awareness, and stigma associated with movement disorders, while highlighting strategies like patient assistance programs, early screening protocols, provider education initiatives, and collaborative care models to overcome these obstacles and improve access to effective treatment.
Video series above is prompted by the following:
- What are common barriers that prevent the optimization of therapy for TD, and what strategies do you utilize to overcome these barriers?
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Encouraging Successful Completion of the Shingles Vaccine Series
September 16th 2025
- A Pharmacist’s View of Emerging CML Treatment
September 4th 2025
- Potential for Precision: Exploring Targeted Therapies in mCRC Care
September 4th 2025
- Empowering Pharmacists in the Management of Patients With Urothelial Cancer
September 3rd 2025
- Empowering Pharmacists in the Management of Patients With Urothelial Cancer
September 1st 2025